SARS-CoV-2 Variants and COVID-19 in Bangladesh-Lessons Learned

被引：0
|
作者：
Lytton, Simon D. [1 ]
Ghosh, Asish Kumar [2 ]
机构：
[1] SeraDiaLogistics, D-81545 Munich, Germany
[2] Dhaka Med Coll Hosp, Dept Virol, Dhaka 1000, Bangladesh
来源：
VIRUSES-BASEL | 2024年 / 16卷 / 07期
关键词：
Bangladesh; COVID-19; SARS-CoV-2; variants; vaccination coverage; pandemic preparedness; IMMUNE ESCAPE; CHALLENGES;
D O I：
10.3390/v16071077
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
The coronavirus infectious disease-2019 (COVID-19) in Bangladesh is a paradigm for how one of the most densely populated countries in the world, with 1270 people per square kilometer, managed to cope with the COVID-19 pandemic under extraordinary circumstances. This review highlights the SARS-CoV-2 variants in Bangladesh and the timeline of their detection in the context of the global experience with the management of vaccination and natural SARS-CoV-2 infection. The motivation to overcome the COVID-19 vaccine dilemma and track Bangladeshi SARS-CoV-2 sub-variants underscores the potential for a low-income country to excel in international medical science, despite having stressed health care services and limited availability of resources for SARS-CoV-2 testing and gene sequencing.
引用
收藏
页数：15
相关论文
共 50 条
  • [21] Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
    Li, Tianhong
    Luo, Kathy Qian
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (11): : 4642 - 4647
  • [22] Focus on SARS-CoV-2 and COVID-19
    Chen, Sharon C-A.
    Rawlinson, William D.
    PATHOLOGY, 2020, 52 (07) : 743 - 744
  • [23] SARS-CoV-2 and the pandemic of COVID-19
    Adil, Md Tanveer
    Rahman, Rumana
    Whitelaw, Douglas
    Jain, Vigyan
    Al-Taan, Omer
    Rashid, Farhan
    Munasinghe, Aruna
    Jambulingam, Periyathambi
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1144) : 110 - 116
  • [24] COVID-19 severity from Omicron and Delta SARS-CoV-2 variants
    Wrenn, Jesse O.
    Pakala, Suman B.
    Vestal, Grant
    Shilts, Meghan H.
    Brown, Hunter M.
    Bowen, Sara M.
    Strickland, Britton A.
    Williams, Timothy
    Mallal, Simon A.
    Jones, Ian D.
    Schmitz, Jonathan E.
    Self, Wesley H.
    Das, Suman R.
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2022, 16 (05) : 832 - 836
  • [25] Recipients of COVID-19 vaccines face challenges of SARS-CoV-2 variants
    Li, Tianhong
    Luo, Kathy Qian
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (12): : 4642 - 4647
  • [26] COVID-19 vaccines: Keeping pace with SARS-CoV-2 variants Comment
    Cevik, Muge
    Grubaugh, Nathan D.
    Iwasaki, Akiko
    Openshaw, Peter
    CELL, 2021, 184 (20) : 5077 - 5081
  • [27] Coronavirus, COVID-19 and SARS-CoV-2
    Megias, Jorge
    REVISTA HISPANOAMERICANA DE HERNIA, 2020, 8 (02) : 111 - 111
  • [28] Characteristics of SARS-CoV-2 and COVID-19
    Ben Hu
    Hua Guo
    Peng Zhou
    Zheng-Li Shi
    Nature Reviews Microbiology, 2021, 19 : 141 - 154
  • [29] Modeling the impact of SARS-CoV-2 variants and vaccines on the spread of COVID-19
    Ramos, A. M.
    Vela-Perez, M.
    Ferrandez, M. R.
    Kubik, A. B.
    Ivorra, B.
    COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION, 2021, 102
  • [30] Dementia and SARS-Cov-2/COVID-19
    Zieschang, T.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S14 - S14
12345